Skip to search formSkip to main contentSkip to account menu

octamethyl pyrophosphoramide

Known as: octamethyldiphosphoramide 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Cholinesterase InhibitorsInsecticidesOrganophosphorus Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Diffusion coefficient of octamethyl-cyclotetrasiloxane in cyclohexane
2017
2017
The dielectric response of polyethylene/polyhedral oligomeric silsesquioxanes composites at various temperatures
Low density polyethylene/polyhedral oligomeric silsesquioxanes (LDPE/POSS) composites were fabricated by extrusion. Three types… 
2011
2011
Synthesis, structure and spectroscopic properties of calix[4]phloroglucinarene dodecamethyl ether and its trifluoroacetic acid complex.
The action of trifluoroacetic acid (TFA) on 2,4,6-trimethoxybenzyl alcohol 3 affords the title tetrameric compound in high yield… 
2009
2009
ITC and NMR spectroscopy binding studies of meso- octamethyl-calix[4]pyrrole and its derivatives
1983
1983
Identification of the probable site of synthesis of butyrylcholinesterase in the superior cervical and ciliary ganglia of the cat.
The source of butyrylcholinesterase (acylcholine acylhydrolase, EC 3.1.1.8) in the ganglion cells of the cat superior cervical… 
1971
1971
Loss of histochemically demonstrable catecholamines and acetylcholinesterase from sympathetic nerve fibres of the pineal body of the rat after chemical sympathectomy with 6-hydroxydopamine
SynopsisNewborn albino rats were injected daily for 8 days with 50 μg/g of 6-hydroxydopamine. They were killed 3 weeks after the… 
1969
1969
Altered sensitivity to drugs following repeated injections of a cholinesterase inhibitor to rats.
1966
1966
Adaptation to octamethyl pyrophosphoramide in rats.
1954
1954
Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
Excerpt In 1935 neostigmine1was introduced as an agent for the treatment of myasthenia gravis. It is still the drug of choice but… 
1953
1953
Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations.
Octamethyl pyrophosphoramide (OMPA) is the most recent organic phosphorus anticholinesterase agent used in the treatment of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)